Acipimox ( DrugBank: Acipimox )
2 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 78 | 下垂体前葉機能低下症 | 2 |
| 265 | 脂肪萎縮症 | 1 |
78. 下垂体前葉機能低下症
臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02782208 (ClinicalTrials.gov) | February 10, 2016 | 18/5/2016 | Lipolytic Effects of GH in Hypopituitary Patients in Vivo | Lipolytic Effects of GH in Hypopituitary Patients in Vivo: Molecular Mechanisms and Temporal Patterns. | Hypopituitarism;Insulin Resistance;Endocrine System Diseases;Glucose Metabolism Disorders;Metabolic Diseases;Pituitary Diseases;Brain Diseases | Drug: Acipimox;Drug: Placebo;Drug: GH substitution;Other: GH pause | University of Aarhus | NULL | Completed | 18 Years | 70 Years | Male | 9 | N/A | Denmark |
| 2 | NCT01209416 (ClinicalTrials.gov) | June 2012 | 24/9/2010 | The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin | The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin | Metabolism;Insulin Resistance;Hypopituitarism | Drug: Acipimox;Drug: Ghrelin;Other: Placebo | University of Aarhus | NULL | Completed | 18 Years | 65 Years | Male | 8 | N/A | Denmark |
265. 脂肪萎縮症
臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00246402 (ClinicalTrials.gov) | September 2002 | 27/10/2005 | Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV | Anti-Lipolytic Strategy for HIV Lipodystrophy | Insulin Resistance;Cardiovascular Diseases;Heart Diseases;HIV Infections;Hypertriglyceridemia;Hyperlipidemia | Drug: Acipimox | National Heart, Lung, and Blood Institute (NHLBI) | NULL | Completed | 18 Years | 65 Years | Both | 30 | N/A | United States |